Amanote Research

Amanote Research

    RegisterSign In

Targeting the Hypoxia Pathway to Treat Pancreatic cancer

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s80888
Full Text
Open PDF
Abstract

Available in full text

Categories
Drug DiscoveryPharmacologyPharmaceutical Science
Date

April 1, 2015

Authors
Jun ZhangLori EricksonEdward Highsmith Jr.Peiwen Fei
Publisher

Informa UK Limited


Related search

Targeting the Hypoxia-Inducible Factor (HIF) Pathway in Cancer

Expert Reviews in Molecular Medicine
Molecular MedicineMolecular Biology
2009English

Heritable Cancer Syndromes Related to the Hypoxia Pathway

Frontiers in Oncology
Cancer ResearchOncology
2016English

Targeting the Alternative NF-κB Pathway in Pancreatic Cancer: A New Direction for Therapy?

Expert Review of Anticancer Therapy
OncologyPharmacology
2013English

Targeting eNOS in Pancreatic Cancer

Cancer Research
Cancer ResearchOncology
2012English

Targeting Pancreatic Cancer Stem Cells

Journal of Cancer Sciences
2015English

Hypoxia Induced Tumor Metabolic Switch Contributes to Pancreatic Cancer Aggressiveness

Cancers
Cancer ResearchOncology
2010English

Encapsulated Irinotecan Provides Novel Option for Hard-To-Treat Pancreatic Cancer

Journal of Community and Supportive Oncology
OncologyHematology
2016English

Specific Targeting of IL-6 Signalling Pathway: A New Way to Treat IBD?

Gut
Gastroenterology
2000English

Targeting the IDO1 Pathway in Cancer: From Bench to Bedside

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy